Mentor Integration Study

February 3, 2016 updated by: University of Wisconsin, Madison

Mentor Integration Project

This study will investigate the benefits of CHESS, a Human Cancer Mentor and the potential additional benefit of combining CHESS and a Cancer Mentor compared to Internet access for women diagnosed with breast cancer. Our goal is to advance interactive cancer communication systems, thus improving quality of life for patients and families facing cancer, especially underserved populations.

Primary Aims:

  • Determine if the Internet, CHESS, a Cancer Mentor, or a combination of CHESS and the Cancer Mentor improve quality of life for women with breast cancer
  • Determine which of the above conditions is most effective
  • Determine which of the above conditions is most cost efficient

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

126

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Connecticut
      • Hartford, Connecticut, United States, 06102
        • Hartford Hospital
    • Texas
      • Houston, Texas, United States, 77030
        • M.D. Anderson
    • Wisconsin
      • Madison, Wisconsin, United States, 53706
        • University Of Wisconsin

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

Eligibility for this protocol is as follows:

  • All subjects must be within 2 months of their primary breast cancer diagnosis,
  • All subjects must be at least 18 years of age,
  • All subjects must be able to read and write English at the 6th-grade level
  • Not homeless

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: CHESS Condition
Subjects who receive the CHESS (Comprehensive Health Enhancement Support System)
Behavioral: CHESS (Comprehensive Health Enhancement Support System) and Human Cancer Mentor
computer based education and support
Experimental: Mentor Condition
Subjects who receive access to a Human Cancer Mentor only
Behavioral: CHESS (Comprehensive Health Enhancement Support System) and Human Cancer Mentor
computer based education and support
Experimental: CHESS + Mentor
Subjects who receive the CHESS system plus a Human Cancer Mentor
Behavioral: CHESS (Comprehensive Health Enhancement Support System) and Human Cancer Mentor
computer based education and support
No Intervention: Internet Only
Subjects receive routine care and nothing else

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Patient quality of life
Time Frame: throughout study
throughout study

Secondary Outcome Measures

Outcome Measure
Time Frame
Self efficacy
Time Frame: throughout study
throughout study
Emotional well being
Time Frame: throughout study
throughout study

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University of Wisconsin, Madison

Collaborators

National Cancer Institute (NCI)

Investigators

  • Principal Investigator: Robert Hawkins, PhD., University of Wisconsin, Madison

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2003

Primary Completion (Actual)

September 1, 2008

Study Completion (Actual)

September 1, 2008

Study Registration Dates

First Submitted

April 30, 2007

First Submitted That Met QC Criteria

May 1, 2007

First Posted (Estimate)

May 2, 2007

Study Record Updates

Last Update Posted (Estimate)

February 5, 2016

Last Update Submitted That Met QC Criteria

February 3, 2016

Last Verified

February 1, 2016

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 2003-192
  • 1P50CA09817-01A1 (National Cancer Institute)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe